Sheikh, Omar http://orcid.org/0000-0003-1291-497X
Yokota, Toshifumi http://orcid.org/0000-0001-7316-3546
Funding for this research was provided by:
wchri
Article History
Received: 22 July 2021
Accepted: 25 October 2021
First Online: 19 November 2021
Declarations
:
: TY is a founder and shareholder of OligomicsTx, which aims to commercialize antisense oligonucleotide technology. OS has no conflicts of interest to report.
: Not applicable.
: Not applicable.
: Not applicable.
Free to read: This content has been made available to all.